Axikin Pharmaceuticals

Biotechnology, Health Care, Life Science
Founded in 2008-01-01
San Diego, California, United States
For Profit

About Axikin Pharmaceuticals

Axikin Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis. Axikin was spun out from Actimis Pharmaceuticals, in June 2008.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 2 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 18500000 USD
  • Last Funding: 6500000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Axikin Pharmaceuticals actively uses 2 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Life Science

Headquarters: San Diego, California, United States